Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 11—November 2026
Research
Five-Biomarker Definition for Hypervirulent Klebsiella pneumoniae Bloodstream Infection and Abscess Complications, Japan, 2022–2024
Naoki Watanabe
, Tomohisa Watari, Yoshihito Otsuka, and Tomoh Matsumiya
, Tomohisa Watari, Yoshihito Otsuka, and Tomoh Matsumiya
Figure 2
Figure 2. Abscess complications among 207 episodes of Klebsiella pneumoniae bloodstream infection by biomarker group in study of hypervirulent K. pneumoniae, Japan, 2022–2024. Stacked bars show mutually exclusive categories of liver abscess only, nonhepatic abscess only, and both liver and nonhepatic abscesses. Bar height represents the percentage of episodes with any abscess complication; numbers within colored bar segments indicate case counts. Case counts and percentages are provided below each bar.
Page created: September 16, 2026
Page updated: October 14, 2026
Page reviewed: October 14, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.